Prime Medicine, Inc. (PRME): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

148.76M
Year ended 2025-12-31
+63.7%
3-year compound annual growth
n/m
5-year compound annual growth
2020-12-31: 2.64M2021-12-31: 12.97M2022-12-31: 33.89M2023-12-31: 90.97M2024-12-31: 118.60M2025-12-31: 148.76M148.76M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31148.76M+25.4%2026-03-03, From 2025-01-01
2024-12-31118.60M+30.4%2026-03-03, From 2024-01-01
2023-12-3190.97M+168.4%2025-02-28, From 2023-01-01
2022-12-3133.89M+161.2%2024-03-01, From 2022-01-01
2021-12-3112.97M+391.5%2023-03-09, From 2021-01-01
2020-12-312.64Mn/a2023-03-09, From 2020-01-01